Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac N.V (CVAC) EPS (Basic): 2018-2024

Historic EPS (Basic) for CureVac N.V (CVAC) over the last 7 years, with Dec 2024 value amounting to $0.77.

  • CureVac N.V's EPS (Basic) fell 14.59% to $0.29 in Q2 2025 from the same period last year, while for Jun 2025 it was $2.03, marking a year-over-year increase of 268.94%. This contributed to the annual value of $0.77 for FY2024, which is 160.60% up from last year.
  • Per CureVac N.V's latest filing, its EPS (Basic) stood at $0.77 for FY2024, which was up 160.60% from -$1.27 recorded in FY2023.
  • In the past 5 years, CureVac N.V's EPS (Basic) registered a high of $0.77 during FY2024, and its lowest value of -$2.53 during FY2021.
  • Its 3-year average for EPS (Basic) is -$0.62, with a median of -$1.27 in 2023.
  • Its EPS (Basic) has fluctuated over the past 5 years, first slumped by 116.37% in 2021, then surged by 160.60% in 2024.
  • Over the past 5 years, CureVac N.V's EPS (Basic) (Yearly) stood at -$1.17 in 2020, then slumped by 116.37% to -$2.53 in 2021, then spiked by 46.73% to -$1.35 in 2022, then grew by 5.73% to -$1.27 in 2023, then spiked by 160.60% to $0.77 in 2024.